Emerging Role of Serum Glucocorticoid-Regulated Kinase 1 in Pathological Pain
Authors:
Open Access
- 20 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 14
Abstract
Currently, the management of acute and chronic pain in clinical practice remains unsatisfactory due to the existence of limited effective treatments, and novel therapeutic strategies for pathological pain are urgently needed. In the past few decades, the role of serum and glucocorticoid-inducible kinase 1 (SGK1) in the development of pain and diurnal rhythms has been implicated in numerous studies. The expression levels of SGK1 mRNA and protein were found to be elevated in the spinal cord and brain in various pathological pain models. Blocking SGK1 significantly attenuated pain-like responses and the development of pathological pain. These studies provide strong evidence that SGK1 plays a role in the development of various types of pathological pain and that targeting SGK1 may be a novel therapeutic strategy for pain management. In this review article, we provide evidence from animal models for the potential role of SGK1 in the regulation of pathological pain caused by inflammation, nerve injury, psychiatric disorders, and chronic opioid exposure.Keywords
This publication has 86 references indexed in Scilit:
- Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic painJournal of Clinical Investigation, 2013
- Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesisProceedings of the National Academy of Sciences, 2013
- The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?Psychoneuroendocrinology, 2011
- Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memoryMolecular Psychiatry, 2010
- Molecular Basis for the Dosing Time-Dependency of Anti-Allodynic Effects of Gabapentin in a Mouse Model of Neuropathic PainMolecular Pain, 2010
- Regulation of Gene Expression in Brain Tissues of Rats Repeatedly Treated by the Highly Abused Opioid Agonist, Oxycodone: Microarray Profiling and Gene Mapping AnalysisDrug Metabolism and Disposition, 2010
- The physiological impact of the serum and glucocorticoid-inducible kinase SGK1Current Opinion in Nephrology and Hypertension, 2009
- Adaptive Variation Regulates the Expression of the Human SGK1 Gene in Response to StressPLOS Genetics, 2009
- A brain-specific SGK1 splice isoform regulates expression of ASIC1 in neuronsProceedings of the National Academy of Sciences, 2008
- CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic painEuropean Journal of Immunology, 2008